40
Participants
Start Date
August 4, 2017
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Carboplatin and Paclitaxel
Paclitaxel 80mg/m2 will be administered over approximately 1 hour as an IV infusion on Days 1,8, and 15 of each 21-day cycle. Carboplatin AUC6 will be administered as approximately a 30 minute IV infusion, following paclitaxel administration on Day 1 of each 21-day cycle.
Nivolumab
Nivolumab 360mg will be infused IV over approximately 30 min on Day 1 of Cycles 1-6 (to 8) of each 21 day cycle. During the maintenance phase, Nivolumab 480mg will be infused IV over approximately 30 min on day 1 of each 28 day cycle, for up to 12 months. During the maintenance period, each cycle is 4 weeks
Cytoreductive surgery
Cytoreductive surgery
Ipilimumab
Ipilimumab 1mg/kg every 6 weeks x 3-6 cycles in the neoadjuvant setting (maximum 2 doses of ipilimumab)
Memorial Sloan Kettering Cancer Center, New York
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER